Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.2K Hold
100
0.02% 133
2025
Q4
$32.7K Hold
100
0.02% 125
2025
Q3
$28.2K Hold
100
0.02% 130
2025
Q2
$27.9K Hold
100
0.02% 126
2025
Q1
$31.2K Hold
100
0.02% 119
2024
Q4
$26.1K Buy
+100
New +$29.7K 0.02% 129

Other funds holding AMGN

Pinney & Scofield's AMGN Position: Q1 2026 in Review

Pinney & Scofield held its Amgen (AMGN) position steady in Q1 2026 at 100 shares worth $35.2K. The position accounts for 0.02% of the portfolio, ranked #133.

Pinney & Scofield first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Pinney & Scofield held 100 shares of Amgen worth $35.2K as of Q1 2026.
  • Pinney & Scofield left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.02% of Pinney & Scofield's portfolio in Q1 2026, its #133 holding.
  • Pinney & Scofield first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Pinney & Scofield's 13F filing for Q1 2026, filed 15 May 2026.